Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $291.94B.
ENTERPRISE VALUE (EV)
$291.94B
Novartis AG
Market Cap
$268.00B
Enterprise Value (EV)
$291.94B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Novartis AG (NVS) | $268.00B | $291.94B |
| AstraZeneca PLC (AZN)vs › | $243.33B | $270.65B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $242.11B | $280.60B |
| Amgen Inc. (AMGN)vs › | $217.52B | $260.84B |
| Roche Holding AG (RHHBY)vs › | $332.94B | $365.44B |
| UnitedHealth Group Incorporated (UNH)vs › | $337.74B | $382.48B |
| Merck & Co., Inc. (MRK)vs › | $356.40B | $403.45B |
| Gilead Sciences, Inc. (GILD)vs › | $179.47B | $202.54B |
| Abbott Laboratories (ABT)vs › | $168.71B | $196.22B |
| Novo Nordisk A/S (NVO)vs › | $165.72B | $180.30B |
Market Cap
$268.00B
Total Debt
$35.38B
Cash
$11.44B
Enterprise Value
$291.94B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
